240 related articles for article (PubMed ID: 18951435)
1. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis.
Phillips M; Allen C; Gerson P; McClain K
Pediatr Blood Cancer; 2009 Jan; 52(1):97-101. PubMed ID: 18951435
[TBL] [Abstract][Full Text] [Related]
2. Preliminary study on the evaluation of Langerhans cell histiocytosis using F-18-fluoro-deoxy-glucose PET/CT.
Zhou W; Wu H; Han Y; Wang S; Dong Y; Wang Q
Chin Med J (Engl); 2014; 127(13):2458-62. PubMed ID: 24985583
[TBL] [Abstract][Full Text] [Related]
3. Discrepancies between F-18-FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis.
Ferrell J; Sharp S; Kumar A; Jordan M; Picarsic J; Nelson A
Pediatr Blood Cancer; 2021 Apr; 68(4):e28891. PubMed ID: 33442960
[TBL] [Abstract][Full Text] [Related]
4. Role of
Albano D; Bosio G; Giubbini R; Bertagna F
Jpn J Radiol; 2017 Oct; 35(10):574-583. PubMed ID: 28748503
[TBL] [Abstract][Full Text] [Related]
5. Coincidence FDG-PET in the evaluation of Langerhans' cell histiocytosis: preliminary findings.
Binkovitz LA; Olshefski RS; Adler BH
Pediatr Radiol; 2003 Sep; 33(9):598-602. PubMed ID: 12879314
[TBL] [Abstract][Full Text] [Related]
6. FDG PET-CT in pediatric Langerhans cell histiocytosis.
Jessop S; Crudgington D; London K; Kellie S; Howman-Giles R
Pediatr Blood Cancer; 2020 Jan; 67(1):e28034. PubMed ID: 31599488
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis.
Lee HJ; Ahn BC; Lee SW; Lee J
Ann Nucl Med; 2012 Nov; 26(9):730-7. PubMed ID: 22797842
[TBL] [Abstract][Full Text] [Related]
8.
Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693
[TBL] [Abstract][Full Text] [Related]
9. Selective CT for PET/CT: dose reduction in Langerhans cell histiocytosis.
Gelfand MJ; Sharp SE; Palumbo JS
Pediatr Radiol; 2015 Jan; 45(1):81-5. PubMed ID: 25149158
[TBL] [Abstract][Full Text] [Related]
10.
Garcia JR; Riera E; Bassa P; Mourelo S; Soler M
Rev Esp Med Nucl Imagen Mol; 2017; 36(5):325-328. PubMed ID: 28262495
[TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Basu S; Li G; Bural G; Alavi A
Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
[TBL] [Abstract][Full Text] [Related]
12. The added value of skeletal surveys in the initial evaluation of children diagnosed with Langerhans cell histiocytosis in the era of staging
Rameh V; Voss S; Bedoya MA; Beaulieu D; Zhang D; Degar BA; Tsai A
Pediatr Blood Cancer; 2023 Jan; 70(1):e30057. PubMed ID: 36266951
[TBL] [Abstract][Full Text] [Related]
13. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S
World J Surg Oncol; 2007 Jun; 5():68. PubMed ID: 17584499
[TBL] [Abstract][Full Text] [Related]
14. Application of
Liao F; Luo Z; Huang Z; Xu R; Qi W; Shao M; Lei P; Fan B
Contrast Media Mol Imaging; 2022; 2022():8385332. PubMed ID: 36051931
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis.
Mueller WP; Melzer HI; Schmid I; Coppenrath E; Bartenstein P; Pfluger T
Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):356-63. PubMed ID: 23096080
[TBL] [Abstract][Full Text] [Related]
16. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
[TBL] [Abstract][Full Text] [Related]
17. Langerhans cell histiocytosis of spine: a comparative study of clinical, imaging features, and diagnosis in children, adolescents, and adults.
Huang WD; Yang XH; Wu ZP; Huang Q; Xiao JR; Yang MS; Zhou ZH; Yan WJ; Song DW; Liu TL; Jia NY
Spine J; 2013 Sep; 13(9):1108-17. PubMed ID: 23602327
[TBL] [Abstract][Full Text] [Related]
18. Whole-body MRI of Langerhans cell histiocytosis: comparison with radiography and bone scintigraphy.
Goo HW; Yang DH; Ra YS; Song JS; Im HJ; Seo JJ; Ghim T; Moon HN
Pediatr Radiol; 2006 Oct; 36(10):1019-31. PubMed ID: 16896695
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
20. The value of 18F-FDG PET/CT in Langerhans cell histiocytosis.
An R; Ma X; Wang Y
Ann Nucl Med; 2024 Mar; 38(3):238-245. PubMed ID: 38217750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
